Integrating Latent Classes in the Bayesian Shared Parameter Joint Model
  of Longitudinal and Survival Outcomes by Andrinopoulou, Eleni-Rosalina et al.
Integrating Latent Classes in the Bayesian Shared Parameter Joint
Model of Longitudinal and Survival Outcomes
Eleni-Rosalina Andrinopoulou1, Kazem Nasserinejad2, Rhonda Szczesniak3,4
and Dimitris Rizopoulos1
1. Department of Biostatistics, Erasmus MC, Rotterdam, The Netherlands
2. Department of Hematology, Erasmus MC, Rotterdam, The Netherlands
3. Division of Biostatistics & Epidemiology and Division of Pulmonary Medicine, Cincinnati
Children’s Hospital Medical Center, Cincinnati, United States
4. Department of Pediatrics, University of Cincinnati, Cincinnati, United States
Corresponding author: Eleni-Rosalina Andrinopoulou, Department of Biostatistics, Erasmus
MC, PO Box 2040, 3000 CA Rotterdam, The Netherlands
email: e.andrinopoulou@erasmusmc.nl, Tel: +31/10/7043731, Fax: +31/10/7043014
Abstract
Cystic fibrosis is a chronic lung disease which requires frequent patient monitoring to
maintain lung function over time and minimize onset of acute respiratory events known
as pulmonary exacerbations. It is important to characterize the association between key
biomarkers such as FEV1 and time-to first exacerbation. Progression of the disease is
heterogeneous, yielding different sub-groups in the population exhibiting distinct longitu-
dinal profiles. It is desirable to categorize these unobserved sub-groups according to their
distinctive trajectories. Accounting for these latent classes, in other words heterogeneity,
will lead to improved estimates of association arising from the joint longitudinal-survival
model.
The joint model of longitudinal and survival data constitutes a popular framework
to analyze longitudinal and survival outcomes simultaneously. Two paradigms within
this framework are the shared parameter joint models and the joint latent class models.
The former paradigm allows one to quantify the strength of the association between the
longitudinal and survival outcomes but does not allow for latent sub-populations. The
latter paradigm explicitly postulates the existence of sub-populations but does not directly
quantify the strength of the association.
We propose to integrate latent classes in the shared parameter joint model in a fully
Bayesian approach, which allows us to investigate the association between FEV1 and
time-to first exacerbation within each latent class. We, furthermore, focus on the selec-
tion of the optimal number of latent classes.
KEY WORDS: Cystic fibrosis, joint model, longitudinal outcome, survival outcome, latent
class model
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1 Introduction
Cystic fibrosis (CF) is a lethal genetic disorder that primarily affects the lungs. The
clinical course of CF is marked by progressive loss of lung function and typically results
in respiratory failure. Forced expiratory volume in 1 second (hereafter, FEV1) is the
most important clinical indicator in monitoring lung function decline in patients with
CF. Patients during follow-up might experience acute respiratory events referred to as
pulmonary exacerbations. It is, therefore, of clinical interest to characterize the association
between the longitudinal outcome FEV1 and time-to first exacerbation. The motivation
for our research comes from the US CF Foundation Patient Registry that consists of
patients that were monitored from 2003 until 2015. In particular, we examined a subset
of the Registry which consists of 1016 patients. These patients were six years and older
and were observed with a median number of follow-up visits equal to six (with a range of
1-93 visits). The average age at baseline is 15 years (with a range of 6-21).
Several authors have studied the evolution of lung function over time, as summarized
in a recent review (Szczesniak et al., 2017a), however, to our knowledge little work has
been done regarding the association of the lung function such as FEV1 with time-to-event
outcomes. In particular, joint modeling of longitudinal FEV1 and survival outcomes in
CF was introduced several years ago (Schluchter et al., 2002), but has not been further
used in CF epidemiology due to the computational burden of this approach. Furthermore,
it is well recognized that different unobserved sub-groups of the biomarker FEV1 exhibit
different longitudinal profiles (Szczesniak et al., 2017b). Patients can be categorized in
several sub-groups (latent classes) with different trajectories. It is, therefore, of high
clinical interest to measure the strength of association between FEV1 with the risk of
first exacerbation accounting for the latent trajectories.
The joint model of longitudinal and survival data constitutes a popular framework to
analyze longitudinal and survival outcomes jointly (Tsiatis and Davidian, 2004; Hickey
et al., 2016). In particular, two paradigms within this framework are the shared parameter
joint models and the joint latent class models. The former paradigm links the longitudinal
and the survival process via the random effects (Faucett and Thomas, 1996; Wulfsohn and
Tsiatis, 1997; Brown and Ibrahim, 2003; Rizopoulos and Ghosh, 2011; Rizopoulos, 2012;
Andrinopoulou et al., 2014), which does not allow for latent classes. The latter paradigm
(Lin et al., 2002; Proust-Lima et al., 2014; Rouanet et al., 2016), which associates the two
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processes through latent classes, explicitly postulates the existence of sub-populations but
does not directly quantify the strength of the association.
The aim of the paper is twofold. Firstly, to model the relationship between FEV1
and time-to first exacerbation. For this purpose, we propose a Bayesian shared parameter
joint model that integrates latent classes inherent in this heterogeneous population. This
model will assess the strength of association between the two outcomes while allowing for
latent classes. Secondly, to address a problem that arises in latent class models, which is
the selection of the optimal number of classes. Several approaches have been proposed in
the literature both in frequentist and Bayesian frameworks, including among others the
use of information criterion, Bayes factors and reversible jump MCMC. These approaches
are computationally intensive and can require the fit of several models with different
numbers of classes, which can be time-consuming. To overcome this problem, we will
implement the method of Nasserinejad et al. (2017) to our joint model. This method is a
pragmatic extension of Rousseau and Mengersen (2011) criterion that showed that when
we overfit a mixture model by assuming more latent classes than present in the data, the
superfluous latent classes will asymptotically become empty if the Dirichlet prior on the
class proportions is sufficiently uninformative. Nasserinejad et al. (2017) performed an
extensive simulation study to further investigate this approach and used it as a criterion
also in longitudinal studies for obtaining the optimal number of classes by simply excluding
latent classes that are negligible in proportion.
2 Joint Model Estimation
2.1 Longitudinal submodel
To account for the fact that the population is heterogeneous and consists of G possible
unobserved sub-groups, we postulate a latent class mixed-effects model (Verbeke and
Lesaffre, 1996; Proust and Jacqmin-Gadda, 2005; Proust-Lima et al., 2013). We let yi
denote the longitudinal response vector for the ith patient (i = 1, . . . , n) obtained at
different time points tij > 0, (j = 1, . . . , ni). In particular, we have
yi(t | vi = g) = ηig(t) + i(t) = x>i (t)βg + z>i (t)big + i(t), (1)
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where vi = g (g = 1, . . . , G) presents the latent class indicator, xi(t) denotes the design
vector for the fixed effects regression coefficients βg and zi(t) the design vector for the
random effects big. Moreover, i(t) ∼ N(0, σ2y). For the corresponding random effects, we
assume a multivariate normal distribution, namely
big ∼ N(0,Σbg),
where N denotes the normal distribution and Σbg is the variance-covariance matrix of the
random effects. An individual has a probability piig = P (vi = g) of belonging to latent
class g. Using a multinomial distribution we obtain the class of each individual as,
vi ∼Multinomial(piig).
According to the specification of the latent class mixed-effects submodel (1), both fixed
and random effects are class-specific, whereas the measurement error i(t) is not.
2.2 Survival submodel
We let T∗i denote the true failure time for the i-th individual, and Ci the censoring time.
Moreover, Ti = min(T
∗
i , Ci) denotes the observed failure time and δi = {0, 1} is the
event indicator where zero corresponds to censoring. We postulate a joint model for the
relationship between the survival and the longitudinal outcome. Specifically, we have
hi(t | vi = g) = h0g(t) exp[γ>g wi + αgηig(t)], (2)
where wi is a vector of baseline covariates with a corresponding vector of regression
coefficients γg and h0g(t) is the baseline hazard. Specifically, the B-splines baseline hazard
function is assumed log h0g(t) = γh0g,0 +
∑Q
q=1 γh0g,qBq(t,ν), where Bq(t,ν) denotes the
q-th basis function of a B-spline with knots ν1, . . . , νQ and γh0g the vector of spline
coefficients. The knots are placed at equally spaced percentiles of the observed event
times. Furthermore, αg denotes the association parameter for the gth class. According
to the specification of the survival submodel (2) the baseline covariates, the baseline
hazard and the association parameter are class-specific parameters. The proposed model
goes beyond the standard joint model and joint latent class model where a single or no
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association parameter is assumed and provides a class-specific association. This is a more
realistic assumption for the motivating data set since it is clinically expected that the risk
of the first exacerbation will be higher when the rate of FEV1 decline is faster. Accounting
for these latent classes will lead to improved estimates of association arising from the joint
model.
3 Bayesian Estimation
We employ a Bayesian approach where inference is based on the posterior distribution
of parameters in the model. We use Markov chain Monte Carlo (MCMC) methods to
estimate the parameters of the proposed model. The likelihood of the model is derived
under the assumption that the longitudinal and survival processes are independent given
the random effects. Moreover, the longitudinal responses of each subject are assumed
independent given the random effects (Rizopoulos, 2012). The likelihood contribution for
the i-th patient is written as
p(yi, Ti, δi | vi = g,θ, big) =∑G
g=1 piig
{∏ni
j=1
[
p(yij | vi = g,θy, big)
]
p{Ti, δi | vi = g, ηig(Ti),θs, big}
}
,
where θ = (θ>s ,θ
>
y , piig)
> with θy = (βg, σy,Σbg) and θs = (γg, αg,γh0g).
The likelihood contribution of the longitudinal outcome takes the form
p(yij | vi = g,θy, big) = (2piσy)−1/2 exp
[
−(yij − xij
>βg − zij>big)2
2σ2y
]
.
The likelihood contribution of the survival model is given by
p{Ti, δi | vi = g, ηig(Ti),θs, big} =
exp
[
γh0g,0 +
Q∑
q=1
γh0g,qBq(Ti,ν) + γ
>
g wi + ηig(Ti)αg
]I(δi=1)
×
exp
{
− exp (γ>g wi)
∫ Ti
0
exp
[
γh0g,0 +
Q∑
q=1
γh0g,qBq(s,ν) + ηig(s)αg,
]
ds
}
.
The posterior distribution is written as
p(θ, bg | y,T , δ) =
∏n
i=1 p(yi, Ti, δi | vi = g,θ, big)p(big | vi = g,θy)p(θ).
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where
p(big | vi = g,θy) = [2pi det(Σbg)]−1/2 exp
(
− b
>
igΣ
−1
bg big
2
)
,
and p(θ) denotes the prior distributions.
A commonly used prior in mixture models for the class probability is a Dirichlet
distribution. In particular,
piig = P (vi = g) ∼ Dirichlet(a).
Small values of a = {a1 . . . aG} correspond to a less informative prior and a flat prior
distribution is obtained when each ag is equal to 1. The selection of a is an important
task and will be discussed in Section 3.1. Standard priors can be assumed for the rest
of the parameters. In particular, for the coefficients of the longitudinal fixed effects, the
survival covariates and the baseline hazard, normal priors can be taken. For the variance-
covariance matrix of the random effects we can assume an inverse Wishart prior, while
for the precision parameter of the longitudinal outcome we can assume an gamma prior.
3.1 Selection of Number of Classes
An important task in latent class models is to identify the optimal number of classes.
Several approaches have been previously proposed for choosing the optimal number of
classes in both frequentist and Bayesian settings. Common examples are the Bayesian
information criterion (BIC) (Schwarz et al., 1978), deviance information criterion (DIC)
(Celeux et al., 2006) and other Bayesian approaches such as Bayes factor and reversible
jump MCMC algorithm (Green, 1995). A drawback of the aforementioned approaches
is that they are computationally intensive and some require the fit of models assuming
different numbers of classes, which might be time-consuming for complex models such as
the joint models of longitudinal and survival outcomes.
An interesting alternative was proposed by Rousseau and Mengersen (2011), where
they proved that in overfitted mixture models (with more latent classes than present in
the data), the superfluous latent classes will asymptomatically become empty if the Dirich-
let prior on the class proportion is sufficiently uninformative. Recently, Nasserinejad et al.
(2017) used this approach and proposed a latent class selection procedure for longitudi-
nal models. An overfitted mixture model converged to the true mixture by assigning a
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small portion of individuals to empty classes, if the parameters of the Dirichlet prior a
are smaller than d/2, where d is the number of class-specific parameters. Furthermore,
uninformative priors for the rest of the parameters are required. The steps are described
as follows:
• First, a latent class model with a large enough number of latent classes is fitted.
• Then, the number of non-empty classes at each iteration is calculated as:
gk,opt = G−
G∑
g=1
I
(
nk,g
n
≤ ψ
)
,
where G is the total number of classes, k represents the iteration, nk,g is the number
of patients in class g at iteration k, n is the total number of patients and ψ is a
predifined value.
• After obtaining the non-empty classes per iteration, the posterior mode of the non-
empty classes is calculated.
• Finally, the model with the optimal number of classes which are the non-empty
classes is refitted.
Advantages of this approach are that it is easy to implement even in such complex
models and it is not influenced by the label switching problem since we observe the non-
empty classes at each iteration. The only time that we need to correct for label switching
is when we fit the final model with the optimal number of classes. Furthermore, this
approach requires us to fit the model only two times, (namely one with the high number
of classes and one with the optimal number of classes) instead of assuming all possible
number of classes, therefore decreasing computational burden. It has been shown through
extensive simulations in the longitudinal setting that this method performs better than
alternative model selection criteria such as BIC and DIC (Nasserinejad et al., 2017).
4 Analysis of the CF data
In this section we present the analysis of the motivating data set introduced in Section 1.
Our primary focus is to investigate the association between FEV1 and time-to first ex-
acerbation by taking into account that we have sub-groups with different evolution over
7
Age (years)
FE
V 1
20
40
60
80
100
120
10 15 20 10 15 20 10 15 20
20
40
60
80
100
120
20
40
60
80
100
120
20
40
60
80
100
120
20
40
60
80
100
120
10 15 20 10 15 20
Figure 1: Individual FEV1 evolutions of 25 randomly selected patients with more than two
repeated measurements.
time for FEV1. The first step is to obtain the optimal number of classes that can ex-
plain the heterogeneity of the population. From the literature, it is known that two or
three classes are observed for the evolution of FEV1 outcome (Szczesniak et al., 2017b).
Therefore, for the selection process, we fitted a joint model assuming six classes. For
the longitudinal outcome, we assumed a linear mixed-effects submodel including natural
cubic splines for time (modeled as age, in years) with two internal knots at 13.76 and
17.62 years (corresponding to 33.3% and 66.67% of the observed follow-up times) in both
the fixed and random effects parts. The DIC criterion and subject-specific plots (with
observed and predicted values) were used to investigate the need of non-linear evolution
over time in a mixed-effects linear model. Furthermore, we corrected for some baseline
characteristics. These variables, together with descriptive statistics, are presented in Ta-
ble 1. In Figure 1 the FEV1 evolutions of 25 randomly selected patients with more than
two repeated measurements are presented.
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Table 1: Descriptive statistics of the variables that were used in the model.
Percentage
Gender:
Males 43
Females 57
Number of F508del alleles (genotype):
Homozygous 53
Heterozygous 32
Neither 6
Missing 9
Hispanic:
Yes 8
No 92
White:
Yes 98
No 2
SESlow (Using state/federal or having no
insurance is a marker of low socioeconomic status):
Yes 48
No 52
MRSA (Methicillin-resistant Staphylococcus aureus):
Yes 16
No 84
MSSA (Methicillin-sensitive Staphylococcus aureus):
Yes 21
No 79
Pa (Pseudomonas aeruginosa):
Yes 46
No 54
Aspergillus:
Yes 28
No 72
CFRD (CF-related diabetes):
Normal 73
Impaired 7
CFRD with or without fasting hyperglycemia 19
PancEnzymes (Taking a pancreatic enzyme supplement,
marks pancreatic insufficiency):
Yes 40
No 60
Mean (standard deviation)
Numvisityr
(Number of visits at the last follow-up within the prior year) 5 (3)
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Specifically, the model takes the form,
yi(t) = ηig(t) + i(t) = β0g +
∑3
ω=1 βωgns(Agei, ω)+
β4gGender +
∑7
ω=5 βωgF508 + β8gHispanic + β9gWhite + β10gSESlow+
β11gMRSA + β12gMSSA + β13gPa + β14gaspergillus +
∑16
ω=15 βωgCFRD+
β17gPancEnzymes + β18gnumVisityr +
∑21
ω=19 βωgns(Agei, ω − 18) : Gender+∑30
ω=22 βωgns(Agei, ω − 21) : F508 +
∑33
ω=31 βωgns(Agei, ω − 30) : SESlow+∑3
ω=1 bωgns(Agei, ω) + i(t).
To investigate the association between FEV1 and time-to first exacerbation, we pos-
tulated the proposed joint latent class model:
hi(t,θs) = h0g(t) exp[γgGenderi + αgηig(t)].
For the baseline hazard we assumed a quadratic B-splines basis with 8 equi-distance
internal knots ranging from zero until 19.25 years.
In the Dirichlet distribution for the prior of the class probability, following the rec-
ommendation in Nasserinejad et al. (2017), we assumed a smaller than d/2 (where d is
the number of class-specific parameters). To ensure that we have the same scale for the
coefficients of the covariates in order to easier select uninformative priors, we standard-
ized the FEV1 outcome and the continuous variables (age and numVisityr). Relatively
uninformative priors were selected for the parameters in the model. These priors are as
follows:
• βg ∼ N(0, 1000),
• γg ∼ N(0, 1000),
• γh0g,q ∼ N(0, 1000),
• αg ∼ N(0, 100),
• σ2y ∼ GA−1(0.01, 0.01)
• Σbg ∼W−1(M,df),
where GA−1 denotes the inverse gamma distribution and W−1 denotes the inverse Wishart
distribution with M = diag(0.01) being the scale matrix and df the degrees of freedom
which is set as the total number of the random effects. For the variance of the association
parameter no large variance was required to ensure that we have a uninformative prior
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since, with the standard joint model we obtained an association parameter smaller than
0.1. The selection of the variances of these priors was investigated with simulations.
We ran the MCMC using a single chain with 300,000 iterations, 250,000 burn-in and 10
thinning. The results indicate the presence of three or four classes, assuming that a class
is empty if it contains 10 to 15% of the patients (10%≤ ψ ≤15%). Since it is established
in the literature that two or three classes are present in such populations, we decided to
continue with three classes (Moss et al., 2016; Szczesniak et al., 2017b).
We reran the model assuming three classes and the normal scale of the continuous
covariate age and FEV1 outcome (we standardized only the numVisityr variable). We
ran the MCMCs with a single chain for 500,000 iterations, with a burn-in of 450,000 and
thinning of 10 and we fixed the label switching problem. Convergence was monitored by
trace plots. Table A1 in the Appendix shows the mean and standard deviation of age (at
baseline), FEV1 (at baseline) and number of visits (at last follow-up) per class, while Table
A2 shows the percentage of the categorical variables (at baseline) pes class. In Figure 2 we
illustrate the evolution of the longitudinal outcome in each class assuming patients who
are F508del homozygotes, non-Hispanic, White, without low SES, are not infections with
MRSA, MSSA or aspergillus, do not use pancreatic enzyme, do not have pseudomonas
aeruginosa, have normal CFRD and had five visits within the prior year (which is the
mean value of all observations). In particular, the upper plots represent female patients
while the lower plots represent male patients. We obtain a faster progression in class one
for both females and males. Patients in class two have a stable evolution in the middle of
the follow-up and patients in class three are stable throughout the follow-up period. In
addition, patients in class one and two start from a higher FEV1 compared to patients
in class three. In Figure 3 we illustrate the evolution of the longitudinal outcome in each
class assuming patients who are F508del homozygotes, Hispanic, White, have low SES,
are infections with MRSA, MSSA, aspergillus, use pancreatic enzymes, have pseudomonas
aeruginosa, have impaired CFRD and had eight visits within the prior year. Again, the
upper plots represent female patients while the lower plots represent male patients. We
obtain that patients in these classes start from a lower FEV1 value compared Figure 2. In
addition, we observe a faster progression in class one for both female and male patients.
The mean and the credible interval of the MCMC samples of the association parameters
per class are presented in Figure 4. We obtain a weak association between FEV1 and time-
11
to first exacerbation for the second and third class, while a stronger negative association
for class one.
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Figure 2: Evolution of the longitudinal outcome FEV1 per class assuming patients who are
F508del homozygotes, non-Hispanic, White, without low SES, are not infections with MRSA,
MSSA or aspergillus, do not use pancreatic enzyme, do not have pseudomonas aeruginosa,
have normal CFRD and had five visits within the prior year (which is the mean value of all
observations). The upper plots represent female patients while the lower plots represent male
patients (posterior mean and credible interval).
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Figure 3: Evolution of the longitudinal outcome FEV1 per class assuming patients who are
F508del homozygotes, Hispanic, White, have low SES, are infections with MRSA, MSSA, as-
pergillus, use pancreatic enzymes, have pseudomonas aeruginosa, have impaired CFRD and
had eight visits within the prior year. The upper plots represent female patients while the
lower plots represent male patients (posterior mean and credible interval).
5 Simulations
We performed a series of simulations to investigate the proposed class selection method
on the joint modeling framework.
5.1 Design
We assumed N1 = 350, N2 = 525 and N3 = 1050 patients with maximum number of
repeated measurements equal to ten. To simulate the continuous longitudinal outcome,
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Figure 4: Mean and credible interval of the association parameter per class.
we used the following linear mixed-effects model per data set. In particular,
yi(t) = ηi(t) + i(t) = β0 + β1malei + β2t + b0i + b1it + i(t),
where i ∼ N(0, σ2y) and bi = (b0i, b1i) ∼ N2(0,Σb). For simplicity, we adopted a linear
effect of time for both the fixed and the random part, and corrected for a binary variable
(malei). Time t was simulated from a uniform distribution between zero and 19.5. For
the survival part, we assumed the following model:
hi(t) = h0(t) exp
{
γ>Agei + αηi(t)
}
.
The baseline risk was simulated from a Weibull distribution h0g(t) = ξt
ξ−1. For the
simulation of the censoring times, an exponential censoring distribution was chosen so
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that the censoring rate was between 40% and 60%. Age was simulated from a normal
distribution with mean 45 and standard deviation 15.7.
Under this setting we simulated three different data sets that have different parameters for
the fixed effects in the longitudinal submodel, the baseline covariates and baseline hazard
in the survival submodel, the variance-covariance matrix of the random effects and the
association parameter (more details are presented in Table 2). Figure 5 illustrates the
evolution of the longitudinal outcome per group from the simulation parameters for each
one of the three data sets.
Table 2: Simulation parameters for the three data sets.
β σy diag{Σb} ξ µc γ α
Data set 1
(Intercept) = 8.03 0.69 0.87 1.8 10 (Intercept) = -4.85 0.38
Male = -5.86 0.02 Age = -0.02
Time = -0.16
Data set 2
(Intercept) = -8.03 0.69 0.02 1.4 10 (Intercept) = -4.85 0.08
Male = 12.20 0.91 Age = 0.09
Time = 0.46
Data set 3
(Intercept) = 0.03 0.69 0.28 1.8 10 (Intercept) = 2.85 0.58
Male = -1.96 0.31 Age = -0.12
Time = -0.01
5.2 Analysis
In order to investigate the proposed class selection approach, we applied the model in three
different Scenarios. For Scenario I we combined all three data sets assuming N1 = 350
individuals in each of them, for Scenario II we combined the first two data sets with
N2 = 525 and finally, for Scenario III we used only the first data set with N3 = 1050. We
fitted the proposed joint model assuming six classes where all the parameters were class-
specific except for the measurement error in the mixed-effects model. These include the
fixed effects from the longitudinal submodel (3 parameters), the baseline covariates from
the survival model (2 parameters), the baseline hazard (5 parameters) from the survival
submodel, the variance-covariance matrix of the random effects (3 parameters) and the
association parameter (1 parameter). To simplify the simulations, for the baseline hazard
we assumed quadratic B-splines basis with 4 equally distance internal knots. We assumed
ag = 6.9 which is smaller than the total number of the class-specific parameters divided
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Figure 5: Evolution of the longitudinal outcome per group from the simulation parameters for
each one of the three data sets.
by two. The same priors were used as in the application and we ran the MCMC using a
single chain with 50,000 iterations, 25,000 burn-in and 10 thinning.
We performed 150 simulations per Scenario. We compared our proposed method
with the joint latent class model using function Jointlcmm from the lcmm package in R
developed by Proust-Lima et al. (2015), where we used the BIC as criterion. In particular,
we assumed that the covariates from the fixed effects in the mixed-effects model, the
variance-covariance of the random effects, the baseline covariate and baseline hazard in
the survival model are class-specific. We, furthermore, assumed a cubic M-splines baseline
risk function.
5.3 Results
The results from the different Scenarios assuming different cut off percentage ψ indicating
when a class is defined as empty are illustrated in Table 3. In particular, we present the
percentage of true number of classes and the mode of the number of classes.
For Scenario I, we obtain the highest percentage when assuming ψ to be between 12-
15%. In particular, we obtain around 55% of the time the correct number of classes and
a mode equal to the correct number of classes (three). On the other hand, the BIC in
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the joint latent class model selects only 20% of the time the correct number of classes.
Furthermore, this method seems to underestimate the true number of classes (mode equal
to one).
For Scenario II, we obtain the highest percentage when ψ is between 8-15%. In partic-
ular, we obtain around 50% of the time the correct number of classes and a mode equal to
the correct number of classes (two). On the other hand, the BIC in the joint latent class
model selects only 12% of the time the correct number of classes. Similar to Scenario I,
this method seems to underestimate the true number of classes (mode equal to one).
Finally, for Scenario III, the BIC in the joint latent class model seems to perform
better than the proposed approach where it always selects the correct number of classes
(one). This is not surprising, since the BIC always underestimated the true number of
classes in the previous Scenarios. Using the proposed approach and assuming that the ψ
is equal to 15%, we obtain 43% of the time the correct number of class and a mode equal
to two. In this Scenario some convergence problems were detected. When recalculating
the % and mode including only the simulations that were converged we obtain similar
percentages for the correct number of class and a mode equal to 1 when ψ is 15%.
6 Discussion
In this paper we proposed a shared parameter joint model incorporating latent classes.
Applying it to CF data, this model accounted for patient heterogeneity inherent in the
progression of FEV1. Compared to previously proposed joint latent class models (Proust-
Lima et al., 2014) we obtained the strength of the association between FEV1 and time-to
first exacerbation per group of patients. Finally, we focused on the selection of the optimal
number of classes and used an overfitted mixture model (high number of classes) to obtain
the non-empty classes.
A limitation of this approach is that it requires an intensive computational effort. In
particular, for the class selection, where a model with a high number of classes is required,
the number of parameters increases drastically. This, in combination with the high number
of observations in the CF application increases the computational time that is required.
Considering the difficulty of this model, it is almost impossible to obtain the optimal
number of classes with other Bayesian criterion. Implementing the proposed criterion
is straightforward; however, due to the complexity of the model it is computationally
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Table 3: Simulation results: Cut off ψ, percentage of true number of classes, mode of the
number of classes
ψ (%) true # of classes (%) mode of # of classes
Scenario I:
150 simulations
1 0 6
2 1 6
5 23 5
8 27 4
10 39 4
12 56 3
15 55 3
Scenario II:
150 simulations
1 0 6
2 2 5
5 31 3
8 47 2
10 51 2
12 53 2
15 57 2
Scenario III:
150 simulations
1 0 6
2 0 6
5 0 4
8 11 2
10 23 2
12 34 2
15 43 2
expensive to fit a model with a larger number of classes, e.g., 10. This could also explain
the fact the a higher percentage for the predefined number ψ was required in order to
obtain the non-empty number of classes. It was shown in the simulation analysis that the
BIC always underestimated the true number of parameters and it, therefore, performed
better when the true number of classes was one. Even though, in that Scenario the
proposed method did not work perfectly, it seems to be better than other criteria and
easier to perform.
Although there is a large database available in the US Registry, we used only a sub-
set in order to make it feasible to run the proposed model. This subset has particular
characteristics and it cannot be generalized to all patients in the Registry. Therefore, the
presented results do not reflect the diversity of the whole database.
Possible extensions would be to include more covariates also in the survival submodel
18
in order to take into account extra information regarding the patients. Furthermore, using
the proposed model for obtaining future FEV1 measurement and time-to first exacerbation
probabilities, could lead to more efficient treatment prioritization and clinical management
for patients with CF.
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Appendix
Table A1: Mean (standard deviation) of age at baseline, FEV1 at baseline and number of visits
at last follow-up visit per class.
Age at baseline FEV1 at baseline Numvisityr
(Number of visits at the last
follow-up within the prior year)
Class 1 15 (4) 59 (23) 5 (3)
Class 2 15 (4) 64 (16) 4 (3)
Class 3 14 (5) 46 (16) 5 (3)
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Table A2: Percentage of categorical varibles at baseline per class.
Gender:
Females Males
Class 1 0.32 0.23
Class 2 0.09 0.09
Class 3 0.16 0.11
Number of F508del alleles (genotype):
Homozygous Heterozygous Neither Missing
Class 1 0.27 0.21 0.03 0.04
Class 2 0.12 0.03 0.02 0.01
Class 3 0.14 0.08 0.02 0.02
Hispanic
No Yes
Class 1 0.52 0.03
Class 2 0.16 0.02
Class 3 0.24 0.03
White
No Yes
Class 1 0.01 0.54
Class 2 0.00 0.18
Class 3 0.01 0.26
SESlow (Using state/federal or having no insurance is a marker of low socioeconomic status):
No Yes
Class 1 0.31 0.24
Class 2 0.09 0.09
Class 3 0.12 0.15
MRSA (Methicillin-resistant Staphylococcus aureus):
No Yes
Class 1 0.51 0.04
Class 2 0.17 0.02
Class 3 0.24 0.03
MSSA (Methicillin-sensitive Staphylococcus aureus):
No Yes
Class 1 0.43 0.12
Class 2 0.14 0.04
Class 3 0.22 0.05
Pa (Pseudomonas aeruginosa):
No Yes
Class 1 0.32 0.23
Class 2 0.11 0.07
Class 3 0.17 0.10
Aspergillus:
No Yes
Class 1 0.42 0.13
Class 2 0.14 0.04
Class 3 0.20 0.07
CFRD (CF-related diabetes):
Normal Impaired CFRD with or without
fasting hyperglycemia
Class 1 0.47 0.02 0.07
Class 2 0.15 0.01 0.02
Class 3 0.23 0.01 0.03
PancEnzymes (Taking a pancreatic enzyme supplement, marks pancreatic insufficiency):
No Yes
Class 1 0.49 0.06
Class 2 0.17 0.02
Class 3 0.24 0.03
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